Literature DB >> 16388486

The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience.

John V Williams1, Chiaoyin K Wang, Chin-Fen Yang, Sharon J Tollefson, Frances S House, Josh M Heck, Marla Chu, Jennifer B Brown, Linda D Lintao, Joe D Quinto, David Chu, Richard R Spaete, Kathryn M Edwards, Peter F Wright, James E Crowe.   

Abstract

BACKGROUND: The role that human metapneumovirus (hMPV) plays in the etiology of upper respiratory tract infections (URIs) in children over a period of many years has not been evaluated previously.
METHODS: By use of real-time reverse-transcriptase polymerase chain reaction, we retrospectively tested nasal wash (NW) specimens for hMPV that had been obtained from a cohort of 1532 infants and children with URIs who were prospectively followed for an average of 2.4 years during the period from 1982 to 2001. Virus genes were sequenced, and prospectively collected clinical data were analyzed.
RESULTS: There were 2710 visits for URIs for which routine cultures did not reveal a viral etiology. Archival NW specimens from 2384 of these visits were available. hMPV RNA was detected in 118 (5%) of 2384 specimens. The mean age of the children with hMPV infection was 20 months, and 78% of illnesses occurred from December through May. Acute otitis media (AOM) was detected in 50% of these children. hMPV circulated each year, but the numbers of isolates detected varied by year. Reinfections with both homologous and heterologous strains occurred. Four distinct genetic lineages were present over the 20 years of surveillance, with several different lineages circulating during some seasons.
CONCLUSIONS: hMPV was detected in a substantial number of children with URIs and concomitant AOM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388486      PMCID: PMC1586246          DOI: 10.1086/499274

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Immunity to and frequency of reinfection with respiratory syncytial virus.

Authors:  C B Hall; E E Walsh; C E Long; K C Schnabel
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

2.  Summertime respiratory syncytial virus infection: epidemiology and clinical manifestations.

Authors:  J F Washburne; J A Bocchini; R M Jamison
Journal:  South Med J       Date:  1992-06       Impact factor: 0.954

3.  High-throughput detection of West Nile virus RNA.

Authors:  P Y Shi ; E B Kauffman; P Ren; A Felton; J H Tai; A P Dupuis; S A Jones; K A Ngo; D C Nicholas; J Maffei; G D Ebel; K A Bernard; L D Kramer
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Influenza vaccination in the prevention of acute otitis media in children.

Authors:  T Heikkinen; O Ruuskanen; M Waris; T Ziegler; M Arola; P Halonen
Journal:  Am J Dis Child       Date:  1991-04

5.  Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods.

Authors:  Michael S Forman; Alexandra Valsamakis
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

6.  The stability of serum hepatitis C viral RNA in various handling and storage conditions.

Authors:  T L Fong; F Charboneau; B Valinluck; S Govindarajan
Journal:  Arch Pathol Lab Med       Date:  1993-02       Impact factor: 5.534

7.  Adenovirus infections in young children.

Authors:  K M Edwards; J Thompson; J Paolini; P F Wright
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

8.  Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.

Authors:  G A Prince; R L Horswood; R M Chanock
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

10.  Human metapneumovirus infection among children hospitalized with acute respiratory illness.

Authors:  James A Mullins; Dean D Erdman; Geoffrey A Weinberg; Kathryn Edwards; Caroline B Hall; Frances J Walker; Marika Iwane; Larry J Anderson
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more
  108 in total

1.  A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.

Authors:  Yange Zhang; W Abdullah Brooks; Doli Goswami; Mustafizur Rahman; Stephen P Luby; Dean D Erdman
Journal:  J Virol Methods       Date:  2014-05-23       Impact factor: 2.014

2.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

Review 3.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

4.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Linda D Lintao; Alexis Liem; Marla Chu; John V Williams
Journal:  Arch Virol       Date:  2013-02-06       Impact factor: 2.574

5.  Population-based incidence of human metapneumovirus infection among hospitalized children.

Authors:  John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective cohort study investigating infant viral respiratory illness and the development of asthma and allergic diseases.

Authors:  Tina V Hartert; Kecia Carroll; Tebeb Gebretsadik; Kimberly Woodward; Patricia Minton
Journal:  Respirology       Date:  2010-03-29       Impact factor: 6.424

7.  Human metapneumovirus infections in children.

Authors:  Terho Heikkinen; Riikka Osterback; Ville Peltola; Tuomas Jartti; Raija Vainionpää
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

8.  Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Rohith Piyaratna; Linda D Lintao; Marla Chu; Alexis Liem; Mary Mark; Richard R Spaete; James E Crowe; John V Williams
Journal:  Virol J       Date:  2009-09-09       Impact factor: 4.099

9.  Viral upper respiratory tract infection and otitis media complication in young children.

Authors:  Tasnee Chonmaitree; Krystal Revai; James J Grady; Audra Clos; Janak A Patel; Sangeeta Nair; Jiang Fan; Kelly J Henrickson
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

10.  Humoral immunity to human metapneumovirus infection in adults.

Authors:  Ann R Falsey; Patricia A Hennessey; Maria A Formica; Mary M Criddle; Jamie M Biear; Edward E Walsh
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.